Genea Biomedx
Tom Beckitt currently serves as Chief Operating Officer (Global) at Genea Biomedx, a position held since May 2015. Tom also holds the title of Global Director / Principal Scientist. Prior to this role, Tom worked as a Chartered Chemist at International Animal Health Products from June 2013 to May 2015 and served as Study Director/Project Manager at GlaxoSmithKline from September 2006 to April 2013. Tom's educational background includes a Bachelor of Science (Hons) in Biochemistry from the University of Hertfordshire and an Honours degree in Organic Chemistry and Biochemistry from UCL, complemented by A Levels in Chemistry, Biology, Maths, Music, and General Studies from Tollbar Academy.
Genea Biomedx
1 followers
Looking to achieve optimal clinical outcomes from the use of premium technology in your ART laboratory? Look no further than Genea Biomedx. Our team designs and manufactures state-of-the-art IVF devices that are designed to simplify, standardise, and automate the fertility treatment process and improve the workflow in laboratories. We understand that there are many factors that can impact the success of IVF treatment, which is why we're committed to reducing the impact of uncontrollable variables such as human error or environmental factors. With our innovative technology, we're able to create products that significantly improve ART industry standards around the world. At Genea Biomedx, we're passionate about helping laboratories attain the best outcomes and families achieve their dreams of parenthood. Join us in revolutionizing the IVF industry and discover how our cutting-edge IVF devices can help you achieve optimal clinical outcomes.